The PEDAL trial, sponsored by Oslo University Hospital, aims to evaluate a novel group-based intervention for bipolar disorder that integrates digital tools to address affective lability, a significant unmet need in current treatment paradigms. With an estimated recruitment of 120 participants across five clinical sites in Norway, the trial seeks to demonstrate superior efficacy of the PEDAL intervention over traditional group psychoeducation (TAU). If successful, the intervention could enhance treatment options for bipolar disorder, potentially leading to broader adoption in clinical practice both nationally and internationally. The focus on digital tools may also align with increasing trends towards telehealth and personalized medicine, positioning the PEDAL intervention favorably in a competitive landscape that includes existing psychoeducational programs and digital mental health solutions.